The long-term objectives of this research project are to help define the molecular basis of meningococcal endotoxin (lipooligosaccharide [LOS]), a critical virulence factor of the human pathogen Neisseria meningitidis. Meningococcal infections remain devastating in the United States and worldwide. Current meningococcal vaccines have major limitations and antibiotic-resistant meningococci are emerging, emphasizing the need to better understand the molecular mechanisms involved in meningococcal pathogenesis. This application is directed at understanding the structural-functional relationships and heterogeneity of the meningococcal LOS inner core, Hep/2[GlcNAc/(0/1), Glc/(0/1)] PEA/(0/1/2)-KDO/2 Lipid A. LOS inner core structure influences LOS assembly, human immune recognition of the meningococcus and the interactions of LOS with soluble and cellular human proteins. The goals are to understand meningococcal LOS inner core biosynthesis and how meningococcal LOS inner core structure activates TLR4 and influences recognition by human antibody.
In Specific Aim 1, the molecular basis of the meningococcal LOS inner core assembly and heterogeneity will be further characterized by: (a) structural and genetic analysis of defined mutants that express only lipid A; (b) identification and characterization of meningococcal genes necessary for the variable phosphorylation of meningococcal lipid A; (c) identification and characterization of meningococcal genes involved in the addition and/or removal of phosphate of Hep II.
In Specific Aim 2, the importance of meningococcal LOS inner core structure and heterogeneity in: (a) activation of human Toll 4 receptor (TLR4), and (b) recognition of meningococci by human antibodies will be determined. To accomplish these Aims, genetically defined LOS mutants of meningococci; analytical biochemistry and purified LOS structures; and established human cell and tissue assays will be utilized. Data obtained from the proposed studies has application to the design of meningococcal vaccines currently in development (e.g., inclusion of truncated LOS molecules in outer membrane vesicle or conjugate vaccines) and to the development of therapeutic agents that may treat meningococcal sepsis and meningitis. The studies will also continue to define differences between enteric endotoxin and the unique structure and biology of meningococcal endotoxin. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI033517-10
Application #
6572186
Study Section
Special Emphasis Panel (ZRG1-BM-1 (01))
Program Officer
Taylor, Christopher E,
Project Start
1993-01-01
Project End
2007-12-31
Budget Start
2003-01-15
Budget End
2003-12-31
Support Year
10
Fiscal Year
2003
Total Cost
$269,349
Indirect Cost
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Tzeng, Yih-Ling; Stephens, David S (2015) Antimicrobial peptide resistance in Neisseria meningitidis. Biochim Biophys Acta 1848:3026-31
Tzeng, Y-L; Martin, L E; Stephens, D S (2014) Environmental survival of Neisseria meningitidis. Epidemiol Infect 142:187-90
Rouphael, Nadine G; Stephens, David S (2012) Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol 799:1-20
Dye, Natalie A; Pincus, Zachary; Fisher, Isabelle C et al. (2011) Mutations in the nucleotide binding pocket of MreB can alter cell curvature and polar morphology in Caulobacter. Mol Microbiol 81:368-94
Zughaier, Susu M (2011) Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2. J Leukoc Biol 89:469-80
Zughaier, Susu; Karna, Prasanthi; Stephens, David et al. (2010) Potent anti-inflammatory activity of novel microtubule-modulating brominated noscapine analogs. PLoS One 5:e9165
Zughaier, Susu M; Svoboda, Pavel; Pohl, Jan et al. (2010) The human host defense peptide LL-37 interacts with Neisseria meningitidis capsular polysaccharides and inhibits inflammatory mediators release. PLoS One 5:e13627
Stephens, David S (2009) Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis. Vaccine 27 Suppl 2:B71-7
Lewis, Lisa A; Choudhury, Biswa; Balthazar, Jacqueline T et al. (2009) Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum. Infect Immun 77:1112-20
Williams, Marcie R; Sakurai, Yumiko; Zughaier, Susu M et al. (2009) Transmigration across activated endothelium induces transcriptional changes, inhibits apoptosis, and decreases antimicrobial protein expression in human monocytes. J Leukoc Biol 86:1331-43

Showing the most recent 10 out of 48 publications